3 employees
CritiSense develops technology for the real-time monitoring of patients' metabolic state and as a novel endpoint of resuscitation.
2004
$1.2M
from 3 investors over 3 rounds
CritiSense raised $1.2M on June 21, 2006
Investors: Pontifax Venture Capital and Bridge Investment Fund
CritiSense raised $1M on June 8, 2005
Investors: Pontifax Venture Capital